According to a recent study from Health Strategies Insights by EVERSANA, 35%-45% of pipeline drugs are infusions and injectables that require nursing services, patient education, cold chain, new reimbursement measures and sites of care. Where is the industry headed? Howard Flushman weights in, and provides insights on strategic directions institutions are taking to access the specialty pharmacy segment.
Learn more about our Specialty Pharmacies and Distributors products & capabilities!
Contact us with your questions and data needs, and an expert will follow up shortly.